清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Long-term results of synovectomy in total knee arthroplasty: a prospective, randomized controlled trial

医学 滑膜切除术 外科 随机对照试验 骨关节炎 全膝关节置换术 关节置换术 前瞻性队列研究 运动范围 失血 麻醉 内科学 类风湿性关节炎 病理 替代医学
作者
Wei‐Nan Zeng,Zeping Yu,Simeng Wang,Anjing Chen,Yiping Zeng,Jing Wang,Yujuan Li,Qi Li,Zongke Zhou
出处
期刊:Chinese Medical Journal [Lippincott Williams & Wilkins]
卷期号:136 (1): 73-81 被引量:1
标识
DOI:10.1097/cm9.0000000000002205
摘要

Synovectomy has been introduced into total knee arthroplasty (TKA) with the aim of relieving pain and inflammation of the synovium. However, there are no long-term, comparative data to evaluate the effect of synovectomy in TKA. This study was aimed at assessing pain, function, and complications in patients undergoing synovectomy during TKA for osteoarthritis (OA) at long-term follow-up.This was a prospective randomized controlled trial of 42 consecutive patients who underwent staged bilateral TKA. Patients undergoing the first-side TKA were allocated to receive TKA with or without synovectomy followed by a 3-month washout period and crossover to the other strategy for the opposite-side TKA. The overall efficacy of both strategies was evaluated by determination of blood loss, the Knee Society score (KSS), and knee inflammation conditions during a 3-month postoperative period. The postoperative pain, range of motion (ROM), and complications were sequentially evaluated to compare the two groups until 10 years after surgery.At the 10-year follow-up, both groups had a similarly significantly improved ROM (114.88 ± 9.84° vs. 114.02 ± 9.43°, t = 0.221, P = 0.815) and pain relief with no differences between the two groups (1.0 [1.0] vs. 1.0 [1.5], U = 789.500, P = 0.613). Similar changes in total blood loss, KSS, and knee inflammation were found in both groups during 3 months postoperatively ( P > 0.05). Additionally, there was no significant difference regarding complications and satisfaction between the two groups ( P > 0.05).Synovectomy in conjunction with TKA for primary OA does not seem to provide any benefit regarding postoperative pain, ROM, and satisfaction during a 10-year follow-up. In addition, it may not result in more blood loss and increased incidence of long-term complications. Based on our long-term findings, it should not be performed routinely.Chinese Clinical Trial Registry, ChiCTR-INR-16008245; https://www.chictr.org.cn/showproj.aspx?proj=13334 .
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
mickaqi完成签到 ,获得积分10
1秒前
NexusExplorer应助酷炫的一笑采纳,获得10
6秒前
Silence完成签到 ,获得积分10
9秒前
vampire完成签到,获得积分10
17秒前
26秒前
29秒前
eth完成签到 ,获得积分10
34秒前
creep2020完成签到,获得积分10
34秒前
45秒前
49秒前
乔杰完成签到 ,获得积分10
59秒前
量子星尘发布了新的文献求助10
1分钟前
独孤完成签到 ,获得积分10
1分钟前
1分钟前
我独舞完成签到 ,获得积分10
1分钟前
任性翠安完成签到 ,获得积分10
1分钟前
英俊的铭应助111111111采纳,获得10
1分钟前
疯狂的囧完成签到 ,获得积分10
1分钟前
2分钟前
开心每一天完成签到 ,获得积分10
2分钟前
111111111发布了新的文献求助10
2分钟前
zhang完成签到 ,获得积分10
2分钟前
poki完成签到 ,获得积分10
2分钟前
2分钟前
Jasper应助怪杰采纳,获得10
2分钟前
陌上之心完成签到 ,获得积分10
2分钟前
2分钟前
yi完成签到 ,获得积分10
2分钟前
慕青应助科研通管家采纳,获得10
2分钟前
2分钟前
2分钟前
文献搬运工完成签到 ,获得积分10
2分钟前
怪杰发布了新的文献求助10
2分钟前
蚂蚁踢大象完成签到 ,获得积分10
2分钟前
无敌暴龙战神完成签到,获得积分10
3分钟前
科研通AI2S应助111111111采纳,获得10
3分钟前
量子星尘发布了新的文献求助10
3分钟前
3分钟前
科目三应助Una采纳,获得10
3分钟前
GG完成签到 ,获得积分10
3分钟前
高分求助中
The Mother of All Tableaux Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 2400
Ophthalmic Equipment Market by Devices(surgical: vitreorentinal,IOLs,OVDs,contact lens,RGP lens,backflush,diagnostic&monitoring:OCT,actorefractor,keratometer,tonometer,ophthalmoscpe,OVD), End User,Buying Criteria-Global Forecast to2029 2000
Optimal Transport: A Comprehensive Introduction to Modeling, Analysis, Simulation, Applications 800
Official Methods of Analysis of AOAC INTERNATIONAL 600
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 588
A Preliminary Study on Correlation Between Independent Components of Facial Thermal Images and Subjective Assessment of Chronic Stress 500
T/CIET 1202-2025 可吸收再生氧化纤维素止血材料 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3957101
求助须知:如何正确求助?哪些是违规求助? 3503095
关于积分的说明 11111294
捐赠科研通 3234212
什么是DOI,文献DOI怎么找? 1787802
邀请新用户注册赠送积分活动 870772
科研通“疑难数据库(出版商)”最低求助积分说明 802292